Cognis: FDA Reviewing Lutein Esters Health Claim Petition

Cognis: FDA Reviewing Lutein Esters Health Claim Petition

LA GRANGE, Ill.Cognis Nutrition & Health (www.cognis.com) announced the Food and Drug Administration (FDA) is reviewing the companys petition for a qualified health claim linking consumption of XANGOLD Natural Lutein Esters with a reduced risk of age-related macular degeneration (AMD) and cataracts. FDA is expected to respond to the petition by early 2005. According to Cognis, allowance of the qualified health claim would result in public health benefits and opportunities for manufacturers of eye health products.